The article you are looking for could not be found. Here are a few options that might help you:
- Use the search box in the right sidebar.
- Try scrolling through the monthly archives to the right.
- Try scrolling through the categories at the top of the page.
Here are the most recent posts from American Banking and Market News:
- American Financial Group Inc Declares $0.25 Quarterly Dividend (AFG)
- Sarepta Therapeutics’s Positive Rating Reiterated at RBC Capital (SRPT)
- Google Earns “Hold” Rating from Axiom Securities (GOOGL)
- Nike Stock Rating Reaffirmed by Citigroup Inc. (NKE)
- Sarepta Therapeutics Given a $16.00 Price Target by Robert W. Baird Analysts (SRPT)
- Boeing Given a $196.00 Price Target at Sterne Agee (BA)
- Oppenheimer Reiterates “$45.00″ Price Target for Sarepta Therapeutics (SRPT)
- Roth Capital Reiterates “$19.00″ Price Target for Concert Pharmaceuticals (CNCE)
- Intercept Pharmaceuticals Given a $493.00 Price Target by Wedbush Analysts (ICPT)
- Atlas Resource Partners, L.P. Price Target Cut to $9.00 (ARP)
- BreitBurn Energy Partners L.P. PT Lowered to $5.00 at JPMorgan Chase & Co. (BBEP)
- Deutsche Bank Boosts Ligand Pharmaceuticals Price Target to $94.00 (LGND)
- BP Prudhoe Bay Royalty Trust PT Lowered to $33.00 (BPT)
- Endurance Specialty Holdings Price Target Raised to $68.00 (ENH)
- EV Energy Partners, L.P. Price Target Lowered to $15.00 at JPMorgan Chase & Co. (EVEP)
- Legacy Reserves Price Target Cut to $10.00 (LGCY)
- Mark Hamill’s Nostalgic Cameo on 'The Flash’
- John Lennon’s First Wife Cynthia Lennon Passes Away
- Is Taylor Swift Playing an April Fool’s Joke on Us?
- Microsoft’s Xbox One Standby Mode Is An Energy Drainer – IGN News